Marc A. Judson
#140,365
Most Influential Person Now
Researcher
Marc A. Judson's AcademicInfluence.com Rankings
Marc A. Judsonengineering Degrees
Engineering
#5221
World Rank
#6467
Historical Rank
Electrical Engineering
#1430
World Rank
#1524
Historical Rank
Marc A. Judsoncomputer-science Degrees
Computer Science
#6701
World Rank
#7061
Historical Rank
Computational Linguistics
#1210
World Rank
#1224
Historical Rank
Machine Learning
#2260
World Rank
#2288
Historical Rank
Artificial Intelligence
#2527
World Rank
#2568
Historical Rank
Download Badge
Engineering Computer Science
Marc A. Judson's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Marc A. Judson Influential?
(Suggest an Edit or Addition)Marc A. Judson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Clinical characteristics of patients in a case control study of sarcoidosis. (2001) (1453)
- HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. (2014) (979)
- Practice Guidelines for Diseases Caused by Aspergillus (2000) (760)
- Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference. (2003) (664)
- A case control etiologic study of sarcoidosis: environmental and occupational risk factors. (2004) (641)
- Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. (2006) (598)
- A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. (2000) (457)
- A concise review of pulmonary sarcoidosis. (2011) (433)
- Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). (2001) (393)
- The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. (2014) (360)
- T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. (2015) (347)
- Treatment of sarcoidosis with infliximab. (2005) (312)
- Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline (2020) (295)
- Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. (1999) (291)
- Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial (2008) (274)
- Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosis. (2007) (264)
- Cardiac sarcoidosis. (2009) (237)
- Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. (2000) (234)
- The diagnosis of sarcoidosis. (2008) (234)
- The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. (2012) (224)
- Large-Scale Multi-omic Analysis of COVID-19 Severity (2020) (219)
- Sarcoidosis in America. Analysis Based on Health Care Use. (2016) (201)
- The diagnostic pathway to sarcoidosis. (2003) (196)
- Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease. (2012) (191)
- Two year prognosis of sarcoidosis: the ACCESS experience. (2003) (184)
- Erratum: Allergic bronchopulmonary aspergillosis in cystic fibrosis - State of the art: Cystic Fibrosis Foundation Consensus Conference (Clinical Infectious Diseases (2003) 37:Suppl. 3 (S225-64)) (2004) (183)
- Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group (2018) (182)
- Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study. (2010) (179)
- Thalidomide for chronic sarcoidosis. (2002) (177)
- The Clinical Features of Sarcoidosis: A Comprehensive Review (2015) (173)
- Large-scale Multi-omic Analysis of COVID-19 Severity (2020) (163)
- Health-related quality of life of persons with sarcoidosis. (2004) (163)
- Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis (2014) (155)
- MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting. (2014) (142)
- The treatment of lupus pernio: results of 116 treatment courses in 54 patients. (2009) (130)
- Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. (2011) (129)
- Depression in sarcoidosis. (2001) (126)
- Presenting characteristics as predictors of duration of treatment in sarcoidosis. (2006) (126)
- ERS clinical practice guidelines on treatment of sarcoidosis (2021) (124)
- Neurosarcoidosis: Presentations and Management (2010) (124)
- Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. (2003) (122)
- Sarcoidosis‐Like Reactions Induced by Checkpoint Inhibitors (2018) (114)
- Drug-Induced Sarcoidosis-Like Reactions. (2018) (113)
- An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment. (1999) (113)
- Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel (2018) (111)
- Organizing Pneumonia (2008) (108)
- Job and Industry Classifications Associated With Sarcoidosis in a Case–Control Etiologic Study of Sarcoidosis (ACCESS) (2005) (108)
- Pleural effusions in a series of 181 outpatients with sarcoidosis. (2006) (106)
- The Sarcoidosis Health Questionnaire: a new measure of health-related quality of life. (2003) (104)
- Neurosarcoidosis: Clinical manifestations, diagnosis and treatment. (2012) (103)
- Inhaled iloprost for sarcoidosis associated pulmonary hypertension. (2009) (102)
- Genome-wide search for sarcoidosis susceptibility genes in African Americans (2005) (98)
- Sarcoidosis: a comprehensive review and update for the dermatologist: part II. Extracutaneous disease. (2012) (97)
- Use of fluticasone in acute symptomatic pulmonary sarcoidosis. (2002) (96)
- Sarcoidosis: Clinical Presentation, Diagnosis, and Approach to Treatment (2008) (92)
- Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation. (2009) (90)
- Pulmonary and psychosocial findings at enrollment in the ACCESS study. (2005) (89)
- Disease Burden and Variability in Sarcoidosis (2017) (89)
- The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis. (2015) (87)
- Chronic cutaneous lesions of sarcoidosis. (2007) (87)
- Efficacy and safety of apremilast in chronic cutaneous sarcoidosis. (2012) (86)
- Pathophysiology and clinical management of cardiac sarcoidosis (2015) (85)
- Cellular Responses to Mycobacterial Antigens Are Present in Bronchoalveolar Lavage Fluid Used in the Diagnosis of Sarcoidosis (2009) (85)
- Current and emerging pharmacological treatments for sarcoidosis: a review (2013) (84)
- Airway obstruction arising from blood clot: three reports and a review of the literature. (1999) (81)
- Efficacy of Short-Course, Low-Dose Corticosteroid Therapy for Acute Pulmonary Sarcoidosis Exacerbations (2010) (80)
- Is endosonography guided fine needle aspiration (EUS-FNA) for sarcoidosis as good as we think? (2004) (78)
- Ambrisentan for sarcoidosis associated pulmonary hypertension. (2011) (78)
- Endpoints for clinical trials of sarcoidosis. (2012) (75)
- Allergic bronchopulmonary aspergillosis after infliximab therapy for sarcoidosis: a potential mechanism related to T-helper cytokine balance. (2009) (75)
- Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review. (2020) (74)
- A new tool to assess sarcoidosis severity. (2006) (74)
- Spinal Cord Neurosarcoidosis (2014) (74)
- Hepatic, splenic, and gastrointestinal involvement with sarcoidosis. (2002) (73)
- Clinical outcomes in sarcoidosis after cessation of infliximab treatment (2009) (70)
- The treatment of pulmonary sarcoidosis. (2012) (70)
- Relationship of environmental exposures to the clinical phenotype of sarcoidosis. (2005) (70)
- Molecular profiling and gene expression analysis in cutaneous sarcoidosis: the role of interleukin-12, interleukin-23, and the T-helper 17 pathway. (2012) (70)
- A modern series of percutaneous intracavitary instillation of amphotericin B for the treatment of severe hemoptysis from pulmonary aspergilloma. (2013) (69)
- Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis. (2008) (68)
- Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis. (2017) (67)
- Biomarkers in sarcoidosis (2016) (66)
- A current assessment of rurally linked exposures as potential risk factors for sarcoidosis. (2001) (65)
- Lung transplantation for pulmonary sarcoidosis. (1998) (65)
- Endobronchial lesions in HIV-infected individuals. (1994) (64)
- Sarcoidosis: social predictors of severity at presentation (2004) (61)
- Clinical Features of Extrapulmonary Sarcoidosis Without Lung Involvement (2018) (59)
- Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics. (2006) (57)
- Neurological Deficits During Treatment With Tumor Necrosis Factor-Alpha Antagonists (2011) (57)
- C-reactive protein predicts response to infliximab in patients with chronic sarcoidosis. (2010) (56)
- Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT). (2019) (55)
- Acute pulmonary exacerbations of sarcoidosis. (2012) (53)
- Isolated Neurosarcoidosis: Case Series in 2 Sarcoidosis Centers (2012) (51)
- A sarcoidosis genetic linkage consortium: the sarcoidosis genetic analysis (SAGA) study. (2005) (49)
- Advances in the diagnosis and treatment of sarcoidosis (2014) (48)
- Endoscopic ultrasonography with fine-needle aspiration: an accurate and simple diagnostic modality for sarcoidosis. (1999) (46)
- Inflammatory Profile and Response to Anti-Tumor Necrosis Factor Therapy in Patients with Chronic Pulmonary Sarcoidosis (2011) (46)
- ICU Admission Muscle and Fat Mass, Survival, and Disability at Discharge: A Prospective Cohort Study (2019) (46)
- Successful treatment of widely disseminated acanthamoebiasis. (1999) (45)
- Geographic variation in sarcoidosis in South Carolina: its relation to socioeconomic status and health care indicators. (1999) (45)
- Bullous sarcoidosis: a report of three cases. (1998) (45)
- The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids: a retrospective analysis from a randomized clinical trial. (2014) (42)
- Comparison of sarcoidosis phenotypes among affected African-American siblings. (2006) (41)
- The treatment of pulmonary aspergilloma. (2001) (41)
- The spectrum of biopsy sites for the diagnosis of sarcoidosis. (2005) (41)
- The pleural space and organ transplantation. (1996) (41)
- Clinical phenotypes in sarcoidosis (2014) (40)
- Pleural effusions following lung transplantation. Time course, characteristics, and clinical implications. (1996) (40)
- The role of calcium channel blockers for the treatment of pulmonary arterial hypertension: How much do we actually know and how could they be positioned today? (2015) (40)
- Chronic Facial Sarcoidosis Including Lupus Pernio (2008) (40)
- Corticosteroids in Sarcoidosis. (2016) (39)
- Validation and important differences for the Sarcoidosis Assessment Tool. A new patient-reported outcome measure. (2015) (39)
- Clinical Course of Sarcoidosis in World Trade Center‐Exposed Firefighters (2018) (38)
- Respiratory reovirus 1/L induction of intraluminal fibrosis. A model for the study of bronchiolitis obliterans organizing pneumonia. (1997) (38)
- Clinical aspects of ocular sarcoidosis (2005) (38)
- New advances in the management of pulmonary sarcoidosis (2019) (37)
- Mobilization of secretions in ICU patients (1994) (37)
- Primary pulmonary involvement of Fusarium solani in a lung transplant recipient. (1997) (36)
- Interrelationship between sleep-disordered breathing and sarcoidosis. (2015) (36)
- The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosis. (2006) (35)
- Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial. (2016) (35)
- Pneumothorax in critically ill patients with COVID-19 infection: Incidence, clinical characteristics and outcomes in a case control multicenter study (2021) (35)
- The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis (2008) (35)
- The three tiers of screening for sarcoidosis organ involvement. (2016) (34)
- The "fairy ring": a new radiographic finding in sarcoidosis. (1999) (34)
- Low Levels of NF-κB/p65 Mark Anergic CD4+ T Cells and Correlate with Disease Severity in Sarcoidosis (2010) (33)
- Consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis (2016) (33)
- Environmental Risk Factors for Sarcoidosis (2020) (33)
- Relapses of sarcoidosis: what are they and can we predict who will get them? (2014) (33)
- A conceptual model of health-related quality of life in sarcoidosis (2014) (33)
- Noninvasive Aspergillus pulmonary disease. (2004) (30)
- The indications for the treatment of sarcoidosis: Wells Law (2017) (30)
- Pleural effusion from acute lung rejection. (1997) (29)
- How many organs need to be involved to diagnose sarcoidosis?: An unanswered question that, hopefully, will become irrelevant. (2014) (29)
- Concomitant sarcoidosis and a connective tissue disease: review of the clinical findings and postulations concerning their association. (2013) (29)
- Quality of Life in Sarcoidosis (2017) (28)
- Valproic Acid–Induced Eosinophilic Pleural Effusion: A Case Report and Review of the Literature (2007) (28)
- Current pharmacotherapy of allergic bronchopulmonary aspergillosis (2001) (27)
- A case report of a dactylaria fungal infection in a lung transplant patient. (2001) (27)
- Elevated MicroRNA-33 in Sarcoidosis and a Carbon Nanotube Model of Chronic Granulomatous Disease. (2016) (26)
- Clinical Manifestations, Radiographic Findings, Treatment Options, and Outcome in Sarcoidosis Patients with Upper Respiratory Tract Involvement (2010) (26)
- Strategies for identifying pulmonary sarcoidosis patients at risk for severe or chronic disease (2017) (26)
- The effects of fatigue and treatment with methylphenidate on sustained attention in sarcoidosis. (2005) (26)
- When the Game Changes (2020) (25)
- Diagnosis of pulmonary Kaposi's sarcoma with fiberoptic bronchoscopy and endobronchial biopsy. A report of five cases (1987) (25)
- Pulmonary Physiologic Abnormalities Caused by Pleural Disease (1995) (25)
- Diagnostic accuracy of thoracic ultrasonography to differentiate transudative from exudative pleural effusion. (2020) (25)
- Pneumoperitoneum to treat air leaks and spaces after a lung volume reduction operation. (1997) (24)
- Impact of Systemic Corticosteroids on Healthcare Utilization in Patients With Sarcoidosis (2011) (23)
- Sarcoidosis presenting as bilateral vocal cord paralysis from bilateral compression of the recurrent laryngeal nerves from thoracic adenopathy. (2009) (23)
- Low Levels Of NF-?B/p65 Mark Anergic CD4+ T-cells And Correlate With Disease Severity In Sarcoidosis (2011) (22)
- Cannabinoid oil vaping associated lung injury and its radiographic appearance. (2019) (22)
- Sarcoidosis Associated With an Elevated Serum CA 125 Level: Description of a Case and a Review of the Literature (2007) (22)
- The etiologic agent of sarcoidosis: what if there isn't one? (2003) (22)
- Income and Other Contributors to Poor Outcomes in US Sarcoidosis Patients. (2019) (21)
- Intracavitary voriconazole for the treatment of hemoptysis complicating Pseudallescheria angusta pulmonary mycetomas in fibrocystic sarcoidosis. (2011) (21)
- Distinguishing Asthma from Sarcoidosis: An Approach to a Problem that is not Always Solvable (2013) (20)
- How are cancer and connective tissue diseases related to sarcoidosis? (2015) (19)
- Clinical aspects of portopulmonary hypertension. (2014) (19)
- Highly active antiretroviral therapy for HIV with tuberculosis: pardon the granuloma. (2002) (19)
- Carpal tunnel syndrome in sarcoidosis. (2001) (18)
- Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire (2020) (18)
- Quality of Life Assessment in Sarcoidosis. (2015) (18)
- Paradoxical Reactions and the Immune Reconstitution Inflammatory Syndrome. (2017) (18)
- Quality of life evaluation in sarcoidosis: current status and future directions (2008) (18)
- Rieske iron-sulfur protein induces FKBP12.6/RyR2 complex remodeling and subsequent pulmonary hypertension through NF-κB/cyclin D1 pathway (2020) (18)
- Development and testing of item response theory-based item banks and short forms for eye, skin and lung problems in sarcoidosis (2013) (18)
- The internal consistency of PRO fatigue instruments in sarcoidosis: superiority of the PFI over the FAS. (2013) (18)
- Small fiber neuropathy in sarcoidosis: Something beneath the surface. (2011) (18)
- Carbon Nanotubes and Chronic Granulomatous Disease (2014) (18)
- Mycobacterium scrofulaceum infection presenting as lung nodules in a heart transplant recipient. (1994) (18)
- Endobronchial HIV associated lymphoma. (1994) (18)
- Pleural effusion caused by trapped lung. (2003) (18)
- Is There an Anatomic Explanation for Chest Pain in Patients With Pulmonary Sarcoidosis? (1997) (17)
- Refractory hypotension associated with hypocalcemia and renal disease. (1994) (17)
- Chylothorax in a patient with AIDS and Kaposi's sarcoma. (1990) (16)
- ICU admission body composition: skeletal muscle, bone, and fat effects on mortality and disability at hospital discharge—a prospective, cohort study (2020) (16)
- The management of sarcoidosis by the primary care physician. (2007) (16)
- The role of serum amyloid A staining of granulomatous tissues for the diagnosis of sarcoidosis. (2017) (16)
- The Relationship of Pleural Manometry with Post-Thoracentesis Chest Radiographic Findings in Malignant Pleural Effusion. (2020) (15)
- RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF INFLIXIMAB IN PATIENTS WITH CHRONIC PULMONARY SARCOIDOSIS (2005) (15)
- Allergic bronchopulmonary aspergillosis. (2012) (15)
- Evaluating the Minimal Clinically Important Difference of the King's Sarcoidosis Questionnaire (KSQ) in a Multi-center, Prospective Study. (2020) (14)
- Pneumothorax and bronchopleural fistula during treatment of allergic bronchopulmonary aspergillosis. (1993) (14)
- Income and Other Contributors to Poor Outcomes in U.S. Patients with Sarcoidosis (2020) (14)
- A proposed solution to the clinical assessment of sarcoidosis: the sarcoidosis three-dimensional assessment instrument (STAI). (2007) (14)
- High frequency ultrasound: a novel instrument to quantify granuloma burden in cutaneous sarcoidosis (2017) (14)
- Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes (2021) (13)
- Successful treatment of lupus pernio with adalimumab. (2011) (13)
- Sarcoidosis extent relates to molecular variability (2017) (12)
- Worsening of pulmonary sarcoidosis (2014) (12)
- Unique inflammatory profile is associated with higher SARS-CoV-2 acute respiratory distress syndrome (ARDS) mortality. (2020) (12)
- Bird-years as well as pack-years. (2004) (12)
- The Assessment of Cough in a Sarcoidosis Clinic Using a Validated instrument and a Visual Analog Scale (2017) (12)
- Cardiac sarcoidosis: there is no instant replay. (2005) (12)
- Mediastinal lymphadenopathy in patients undergoing cardiac transplant evaluation. (2011) (11)
- Vaginal involvement in a patient with sarcoidosis. (2010) (11)
- Sevoflurane Induced Diffuse Alveolar Hemorrhage in a young patient (2016) (11)
- Correlation of spleen metabolism assessed by 18F-FDG PET with serum interleukin-2 receptor levels and other biomarkers in patients with untreated sarcoidosis (2015) (11)
- Patient-reported outcome measures for sleep disorders and related problems: clinical and research applications. (2013) (11)
- Therapeutic strategies for pulmonary sarcoidosis (2020) (10)
- Patient perspectives in sarcoidosis. (2019) (10)
- Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis (2020) (10)
- Unique inflammatory profile is associated with higher SARS-CoV-2 acute respiratory distress syndrome (ARDS) mortality (2021) (10)
- Status asthmaticus with acute decompensation with therapy in a 27-year-old woman. (1995) (10)
- Novel ACE mutations mimicking sarcoidosis by increasing blood ACE levels. (2020) (9)
- The Diagnosis of Sarcoidosis: Attempting to Apply Rigor to Arbitrary and Circular Reasoning. (2018) (9)
- COVID-19 and Sarcoidosis, Readiness for Vaccination: Challenges and Opportunities (2021) (9)
- Rapid development of sarcoid tenosynovitis. (2011) (9)
- Screening sarcoidosis patients for cardiac sarcoidosis: What the data really show. (2019) (8)
- Developing better drugs for pulmonary sarcoidosis: determining indications for treatment and endpoints to assess therapy based on patient and clinician concerns (2019) (8)
- Staple metalloptysis after lung resection for mycetoma: a case report and a review of the literature. (2008) (8)
- Management of Advanced Pulmonary Sarcoidosis. (2021) (7)
- Endpoints in sarcoidosis: More like IPF or asthma? (2017) (7)
- The value of sound waves and pleural manometry in diagnosing a pleural effusion with the dual diagnosis (2016) (7)
- Responsiveness to Change and Establishment of the Minimal Clinically Important Difference for the Cutaneous Sarcoidosis Activity and Morphology Instrument. (2019) (7)
- A Delphi Study of Pharmacotherapy for Noncystic Fibrosis Bronchiectasis (2014) (7)
- The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study. (2021) (7)
- Origin of pleural cells after lung transplantation: from donor or recipient? (1997) (7)
- Quantifying the relationship between symptoms at presentation and the prognosis of sarcoidosis. (2019) (7)
- Arrhythmias in Cardiac Sarcoidosis Bench to Bedside (2021) (7)
- A sarcoidosis clinician's perspective of MHC functional elements outside the antigen binding site. (2019) (7)
- Granulomatous lung disease: clinical aspects (2020) (7)
- The development of sarcoidosis in patients receiving daclizumab: A case series from multiple clinical trials. (2019) (7)
- The epidemic of drug‐induced sarcoidosis‐like reactions: a side effect that we can live with (2019) (6)
- The pressure-dependent air leak after partial lung resection (2016) (6)
- Unusual presentations of pulmonary sarcoidosis: cases from the medical university of South Carolina. (2007) (6)
- Treatment of a solitary pulmonary sarcoidosis mass by CT-guided direct intralesional injection of corticosteroid. (2001) (6)
- Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI). (2021) (6)
- ASSESSMENT OF INFLIXIMAB EFFICACY IN EXTRAPULMONARY SARCOIDOSIS USING A NOVEL ASSESSMENT TOOL: RESULTS FROM A RANDOMIZED TRIAL (2005) (6)
- Pneumocystis jerovecii pneumonia in a patient with untreated chronic lymphocytic leukaemia: a novel case and postulations concerning the mechanism (2013) (5)
- Detection of sarcoidosis associated fasciitis by uptake on a FDG PET scan: a novel finding. (2013) (5)
- Sarcoidosis manifested as peripheral pulmonary infiltrates. (1993) (5)
- Corticosteroid refractory sarcoidosis. (2020) (5)
- Acute Pulmonary Exacerbation of Sarcoidosis (2014) (5)
- Pirfenidone for Progressive Fibrotic Sarcoidosis (PIRFS): Results of a Double Blind Placebo Controlled Pilot Study (5)
- Rare case of parathyroid gland sarcoidosis presenting with hypercalcaemia (2019) (5)
- The diagnosis of sarcoidosis. (2019) (5)
- Ambrisentan For Sarcoidosis Associated Pulmonary Hypertension (SAPH) (2010) (4)
- The St. George’s Respiratory Questionnaire in Pulmonary Sarcoidosis (2020) (4)
- Reply to: Monogenic early-onset sarcoidosis is no longer a variant of "idiopathic" sarcoidosis. (2013) (4)
- The therapeutic value of singing. (1984) (4)
- Clinical aspects of lung transplantation. (1993) (4)
- Blastomycosis in the Capital District of New York State: A Newly Identified Emerging Endemic Area. (2020) (4)
- CHEST X-RAY ASSESSMENT USING A DETAILED SCORING METHOD IN A RANDOMIZED TRIAL OF INFLIXIMAB IN SUBJECTS WITH CHRONIC PULMONARY SARCOIDOSIS (2005) (4)
- Infliximab-Induced Hypothyroidism: A Novel Case and Postulations concerning the Mechanism (2013) (4)
- Readdressing the entity of exercise pulmonary arterial hypertension. (2017) (4)
- Patient perspectives in sarcoidosis. (2019) (3)
- Causes of Poor Medication Adherence in Sarcoidosis: Poor Patient-Doctor Communication and Suboptimal Drug Regimens. (2020) (3)
- Methemoglobinemia Caused by Portable Dialysis in the Critically Ill (2017) (3)
- Corticosteroid-Sparing Drugs in Sarcoidosis: How Should We Assess Them? (2021) (3)
- Tuberculous mediastinal lymphadenitis that evolved into pulmonary tuberculosis following transbronchial needle aspiration (2010) (3)
- Management of immunosuppressants in the era of coronavirus disease-2019 (2021) (3)
- A neutropenic patient with rapidly progressive lung lesion. (2004) (3)
- Reply to Bauer and Goff. (2015) (3)
- NEW CONCEPT: NOT EVERY POSTOPERATIVE AIR LEAK IS THE SAME (2019) (3)
- Pneumocystis carinii pneumonia manifested as a hilar mass and cavitary lesion: an atypical presentation in a patient receiving aerosolized pentamidine prophylaxis. (1990) (3)
- Pasteurella multocida pleural effusion: A case report and review of literature (2016) (3)
- Screening Sarcoidosis Patients for Occult Disease (2020) (3)
- The diagnosis of sarcoidosis. (2019) (3)
- A New Radiographic Finding in Sarcoidosis (2015) (3)
- Tissue verification of stage I sarcoidosis: the question is if, not how. (2008) (3)
- Roflumilast (Daliresp®) to reduce acute pulmonary events in fibrotic sarcoidosis: a multi-center, double blind, placebo controlled, randomized clinical trial (2021) (3)
- Assessment of Mediastinal Lymph Node Size in Pneumococcal Pneumonia with Bacteremia (2018) (3)
- Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT1): A Prospective, Multicenter Study of the T2Candida Panel (2017) (3)
- TRADITIONAL RISK FACTORS INCREASE THE RISK OF POOR OUTCOMES IN PATIENTS WITH CARDIAC SARCOIDOSIS (2022) (2)
- A necrotic tonsillar lesion: An unusual presentation of disseminated histoplasmosis (2017) (2)
- Granulomatosis and polyangitis followed by alveolar proteinosis in a 32-year-old woman. (2012) (2)
- Chronic hypoxemia and paraganglioma: a rare case and discussion of potential mechanisms. (2014) (2)
- Value of pulmonary function testing identifying progressive pulmonary disease in fibrotic sarcoidosis: results of a prospective feasibility study. (2022) (2)
- A Case of Primary Tracheal Paraganglioma (2003) (2)
- Antifibrotic drugs for pulmonary sarcoidosis: A treatment in search of an indication. (2021) (2)
- Lupus Pernio or Chilblain Lupus?: Response (2009) (2)
- Sarcoidosis: Lost in translation (2011) (2)
- Concomitant acute sinusitis and acute lung rejection. (2000) (2)
- Effect of SSRIs and SNRIs on Nocturnal Urinary Frequency (2016) (2)
- Sarcoidosis associated pleural effusion: Clinical aspects (2021) (2)
- Reticuloendothelial system involvement in untreated sarcoidosis patients as assessed by 18F-FDG PET scanning. (2016) (2)
- Proteinuria in sarcoidosis: Prevalence and risk factors in a consecutive outpatient cohort (2017) (2)
- Clinical aspects of pulmonary sarcoidosis. (2000) (2)
- Pharyngitis, splenomegaly, and hilar and peripheral adenopathy in a 29-year-old man with acute hypoxic respiratory failure. (2001) (2)
- The time bomb of isolated cardiac sarcoidosis: Is it ticking? (2021) (2)
- Emerging and potential treatment options for sarcoidosis (2018) (2)
- Scout – sarcoidosis outcomes taskforce. A systematic review of outcomes to inform the development of a core outcome set for pulmonary sarcoidosis (2021) (2)
- Genitourinary Sarcoidosis: A Single Institution Experience and Review of the Literature (2010) (2)
- Association between Drainage-Dependent Prolonged Air Leak after Partial Lung Resection and Clinical Outcomes: A Prospective Cohort Study. (2021) (2)
- A Primer on the Clinical Aspects of Sarcoidosis for the Basic and Translational Scientist (2021) (2)
- Inflammatory Pathways in Sarcoidosis. (2021) (1)
- The diagnosis of an intramuscular metastasis aid from a finding on a computerized tomography scan. (1990) (1)
- Faculty Opinions recommendation of Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry. (2019) (1)
- A Bare-Bones Approach. (2017) (1)
- Evaluating the Minimal Clinically Important Difference of the King'S Sarcoidosis Questionnaire (KSQ) in a Multi-Center, Prospective Trial (2020) (1)
- A 23-Year-Old Man With Recurrent Hemoptysis. (2015) (1)
- Intracavitary Voriconazole For Symptomatic Pseudallescheria Boydii Pulmonary Mycetomas In A Patient With Fibrocystic Sarcoidosis (2010) (1)
- Depot Intramuscular Triamcinolone For The Treatment Of Sarcoidosis (2011) (1)
- The association of baseline sarcoidosis measurements with 6-month outcomes that are of interest to patients: Results from the On-line Sarcoidosis Assessment Platform Study (OSAP). (2022) (1)
- Outcomes of prednisone-tapering regimens for cardiac sarcoidosis: A retrospective analysis demonstrating a benefit of infliximab. (2022) (1)
- Determining the cause of pulmonary granulomas: A multidimensional process (2015) (1)
- The Correlation of a Sarcoidosis Clinical Outcome Score to Patient Demographics and Sarcoidosis Organ Involvement (2019) (1)
- Allergic bronchopulmonary aspergillosis: what’s known and what’s new (2016) (1)
- Considerations regarding sarcoidosis in the bariatric surgical patient. (2017) (1)
- Lung Transplantation for Sarcoidosis (2005) (1)
- Intracavitary Amphotericin B For Pulmonary Aspergilloma Complicated By Serious Hemoptysis In Fibrocystic Sarcoidosis (2010) (1)
- CARDIAC SARCOIDOSIS PATIENTS WHO MEET THE 1993 AND 2006 JAPANESE DIAGNOSTIC CRITERIA ARE MORE LIKELY TO HAVE ADVERSE OUTCOMES (2022) (1)
- Role of Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) as a Measure of Self-Reported Health Related Quality of Life in Sarcoidosis Patients (2019) (1)
- A 74-year-old man with chronic lymphocytic leukemia, cough, and a lung mass. (1999) (1)
- MYOCARDIAL INFLAMMATION/FIBROSIS DETECTION BY PULSE-CANCELLATION ECHOCARDIOGRAPHY IN PATIENTS WITH CARDIAC SARCOIDOSIS-CORRELATION WITH FDG-PET (2019) (1)
- Correlation of Health Related Quality of Life Measures in Sarcoidosis Associated Pulmonary Hypertensio (2011) (1)
- Quality of Life and Physical Activity in 629 Individuals With Sarcoidosis: Prospective, Cross-sectional Study Using Smartphones (Sarcoidosis App) (2022) (1)
- Monitoring cardiac sarcoidosis: The next frontier. (2018) (1)
- Validation of the Sarcoidosis Diagnostic Score (SDS) in a Multicontinental Study. (2022) (1)
- Inter-rater reliability of cutaneous sarcoidosis assessment tools via remote photographic assessment (2017) (1)
- Sarcoidosis: Evolving Concepts and Controversies (2007) (1)
- Dysphagia from thoracostomy tube compression of the esophagus after single lung transplantation. (1996) (1)
- RESPONDER ANALYSES IN PATIENTS RECEIVING INFLIXIMAB FOR CHRONIC SARCOIDOSIS WITH PULMONARY INVOLVEMENT (2005) (1)
- The relationship of obesity and obstructive sleep apnea to the development of sarcoidosis: A large retrospective case-control US Veterans Administration analysis. (2022) (1)
- Diagnosis and treatment of allergic bronchopulmonary aspergillosis (2008) (1)
- Fairy Ring Sign on High Resolution Computed Tomography in a Patient With Cryptogenic Organizing Pneumonia (2011) (1)
- Respiratory Medicine: Focus on Sarcoidosis: Editor's welcome. (2017) (1)
- The ability to predict the clinical course of pulmonary sarcoidosis from data that is right in front of us (2022) (0)
- Assessing the reliability of obstructive sleep apnea screening instruments in isolation or in combination (2020) (0)
- Sarcoidosis extra-pulmonary manifestations (2017) (0)
- Estimation of auto-PEEP. (1991) (0)
- Dyspnea Originating Far From the Heart and Lung (2015) (0)
- The Role of Thoracic Ultrasonography in the Diagnosis of Pleural Effusion (2019) (0)
- Lupus Pernio Activity and Severity Index (LuPASI) Score in Sarcoidosis Patients (2004) (0)
- Faculty Opinions recommendation of Toxicity risk from glucocorticoids in sarcoidosis patients. (2019) (0)
- Cardiac Sarcoidosis with Peripheral Lymphopenia is Responsive to Adalimumab Therapy (2022) (0)
- INFLAMMATORY BOWEL DISEASE : A PRACTICAL APPROACH , SERIES # 73 INFLAMMATORY BOWEL DISEASE : PRACTICAL APP OACH (2013) (0)
- Deconstructing Multiorgan Sarcoidosis (2023) (0)
- SARCOIDOSIS ASSOCIATED PULMONARY ARTERIAL HYPERTENSION (SAPAH): CHARACTERISTICS OF PATIENTS ENROLLED IN A PROSPECTIVE, OPEN LABEL TRIAL OF INHALED ILOPROST (2007) (0)
- Faculty Opinions recommendation of Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation. (2014) (0)
- S.23. Expression Profiling of Skin and Peripheral Blood Mononuclear Cells from Patients with Cutaneous Sarcoidosis: An Interleukin-12 and Interferon Signature (2009) (0)
- Physician Mistrust and Discrimination in Sarcoidosis: It’s Real and It’s Prevalent (2021) (0)
- Faculty Opinions recommendation of Lung transplantation for pulmonary sarcoidosis. Twenty-five years of experience in the USA. (2019) (0)
- Response. (2020) (0)
- 10th International Conference on Bronchoalveolar Lavage (2010) (0)
- The Reply. (2020) (0)
- GENDER DIFFERENCES IN CARDIAC SARCOIDOSIS DIAGNOSIS UTILIZING ECG AND IMAGING CRITERIA (2022) (0)
- Response (2021) (0)
- Hypoxia Induced By Sulfasalazine Toxicity (2014) (0)
- Living with sarcoidosis: Virtual roundtable dialogue with patients and healthcare professionals. (2023) (0)
- Activity tracking devices in sarcoidosis (2023) (0)
- ICU Admission Skeletal Muscle Mass and Hospital Outcomes (2016) (0)
- List of Contributors (2019) (0)
- DIAGNOSTIC DILEMMA: Metabolic Disease (2006) (0)
- causative agent on the pathway fromhealth to atherosclerosis to coronary artery disease to cardiovascular death required remarkable discovery science (12). However, without concurrent foundational epidemiologic work (2021) (0)
- Sarcoidosis Epidemiology, Clinical Presentation, Small Fiber Neuropathy, and Options beyond Prednisone (2014) (0)
- Faculty Opinions recommendation of Chronic pulmonary aspergillosis complicating sarcoidosis. (2019) (0)
- Adalimumab in the treatment of cardiac sarcoidosis: Single center case series and narrative literature review (2022) (0)
- Predictors of Cardiac Decompensation in Patients With Cardiac Sarcoidosis Undergoing De-escalation of Treatment (2017) (0)
- THE EFFICACY AND SAFETY OF APREMILAST IN CHRONIC CUTANEOUS SARCOIDOSIS (2010) (0)
- The management of sarcoidosis in the 2020's by the primary care physician. (2023) (0)
- Serum Amyloid a Immunostaining of Granulomatous Tissue as a Novel Diagnostic Test for Sarcoidosis (2016) (0)
- A Rare Case Of Lymphomatoid Granulomatosis With An Initial Presentation Of Isolated Neurologic Abnormalities (2012) (0)
- Proceedings of the 2014 AASOG conference. (2015) (0)
- Faculty Opinions recommendation of Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2. (2014) (0)
- Faculty Opinions recommendation of Fatigue and health-related quality of life in patients with pulmonary sarcoidosis treated by oral Corticosteroids. (2019) (0)
- Faculty Opinions recommendation of Physical inactivity in pulmonary sarcoidosis. (2019) (0)
- The Treatment of ABPA (2009) (0)
- NEUROLOGIC MANIFESTATIONS OF SYSTEMIC DISEASE ( A PRUITT (2013) (0)
- Assessment Of Response To Drug Therapy For Chronic Cutaneous Sarcoidosis (2011) (0)
- Faculty Opinions recommendation of Histopathology of explanted lungs from patients with a diagnosis of pulmonary sarcoidosis. (2019) (0)
- The treatment of sarcoidosis: translating the European respiratory guidelines into clinical practice (2022) (0)
- Identifying a core outcome set for pulmonary sarcoidosis research – the Foundation for Sarcoidosis Research – Sarcoidosis Clinical OUtcomes Taskforce (SCOUT) (2022) (0)
- Treatment of Pulmonary Arterial Hypertension A Step Forward (2003) (0)
- Faculty Opinions recommendation of Short-Term Effects of a Multimodal 3-Week Inpatient Pulmonary Rehabilitation Programme for Patients with Sarcoidosis: The ProKaSaRe Study. (2019) (0)
- Rare organ manifestations of sarcoidosis. (2022) (0)
- Identification of bio-markers in sarcoidosis BAL using multidimensional Differential Display Proteome Analysis coupled with nano-HPLC tandem mass spectrometry (2007) (0)
- Low Prevalence of Cardiac Sarcoidosis Using Routine and Enhanced Screening Strategies in Unselected Sarcoidosis Patients: Preliminary Baseline Data from the Foundation for Sarcoidosis Research Clinical Studies Network Screening Trial (2022) (0)
- NEUROLOGIC MANIFESTATIONS OF SYSTEMIC DISEASE (A PRUITT, SECTION EDITOR) Neurosarcoidosis (2013) (0)
- Cardiac device-induced right to left shunt causing significant hypoxemia: A case report and review of literature (2022) (0)
- Editorial: Novel Insights Into the Immunology of Pulmonary Granulomatous Diseases (2021) (0)
- Faculty Opinions recommendation of Sarcoidosis: patient treatment priorities. (2019) (0)
- Anti-Inflammatory Therapy in Advanced Sarcoidosis: Results from The Registry for Advanced Sarcoidosis (REAS) (2020) (0)
- Expression Profile of Inflammation and Fibrosis Mediators in Tissue Specimens from Cutaneous Sarcoid Lesions (CSL). (2009) (0)
- Repository corticotropin injection (H.P. Acthar gel) for the treatment of sarcoidosis-induced hypercalciuria and vitamin D dysregulation: a pilot, open label study (2018) (0)
- Pirfenidone for Fibrotic Sarcoidosis: Physiology of Study Patients (2020) (0)
- Faculty Opinions recommendation of Potential immunotherapies for sarcoidosis. (2019) (0)
- Proceedings of the 2015 AASOG conference: Reducing disparities in sarcoidosis through personalized care and increased detection (2017) (0)
- Sarcoidosis: Advances in Therapy (2020) (0)
- Potential limitations of activity tracking devices in monitoring effects of treatment for sarcoidosis. (2023) (0)
- clinicalinvestigations '=- ..- . Endobronchial Lesions in HIV-infected Individuals* (2017) (0)
- Trouble below the surface. (2006) (0)
- It's not "just a virus" anymore. (1998) (0)
- DIAGNOSIS OF PULMONARY SARCOIDOSIS USING ENDOBRONCHIAL ULTRASONOGRAPHY WITH TRANSBRONCHIAL NEEDLE ASPIRATION (EBUS-TBNA) AS A PRIMARY DIAGNOSTIC MODALITY (2006) (0)
- Origin ofPleural Cells AfterLung Transplantation* FromDonororRecipient? (2015) (0)
- Diagnosis of Esophagorespiratory Fistula with Methylene Blue (1997) (0)
- Correlation of Change in Diaphragmatic Parameters After Large Volume Thoracentesis in Patients with Symptomatic Pleural Effusions (2020) (0)
- pulmonar andcritical carepearls Status Asthmaticus WithAcuteDecompensation WithTherapy ina 27-Year-Old Woman* (2017) (0)
- Is Fluoroscopy Needed for Bronchoscopic Lung Biopsy?: Pro Fluoroscopy (1994) (0)
- Metastatic Extraspinal Ependymoma Masquerading as Carcinoid Tumor: Diagnosis Based on Endobronchial Ultrasound Guided Biopsy (2011) (0)
- GENDER DISPARITIES IN THE ECHOCARDIOGRAPHIC PRESENTATION OF CARDIAC SARCOIDOSIS (2022) (0)
- ESTIMATION OF AUTO-PEEP. AUTHOR'S REPLY (1991) (0)
- The MUSC lung transplantation program: the first year's experience. (1995) (0)
- Why doesn't anyone want to cure sarcoidosis?: The neglect of disease termination. (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Marc A. Judson?
Marc A. Judson is affiliated with the following schools:
